{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:59:34Z","timestamp":1778230774152,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["955756"],"award-info":[{"award-number":["955756"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejps.2025.107185","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:44:38Z","timestamp":1750851878000},"page":"107185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro evaluation of drug presence in the upper small intestine when antro-duodenal drug transfer of a highly permeable drug occurs after a high-calorie, high-fat meal"],"prefix":"10.1016","volume":"212","author":[{"given":"Shirin","family":"Dietrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridoula","family":"Karagianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Ceulemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bevernage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Reppas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4463-2459","authenticated-orcid":false,"given":"Maria","family":"Vertzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.ejps.2025.107185_bib0002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2008.02.007","article-title":"Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions","volume":"34","author":"Brewster","year":"2008","journal-title":"Eur J Pharm Sci"},{"issue":"467","key":"10.1016\/j.ejps.2025.107185_bib0003","doi-asserted-by":"crossref","first-page":"eaar7047","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejps.2025.107185_bib0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-5173(87)90137-2","article-title":"Gastrointestinal transit of a controlled release pellet formulation of tiaprofenic acid and the effect of food","volume":"35","author":"Davis","year":"1987","journal-title":"Int. J. Pharmaceut."},{"issue":"6","key":"10.1016\/j.ejps.2025.107185_bib0006","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.xphs.2024.01.001","article-title":"Understanding the conditions under which drugs are transferred from the stomach through the upper small intestine after a high-calorie, high-fat meal","volume":"113","author":"Dietrich","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejps.2025.107185_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106798","article-title":"On the processes limiting oral drug absorption when amorphous solid dispersions are administered after a high-calorie, high-fat meal: sporanox\u00ae pellets","volume":"199","author":"Dietrich","year":"2024","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ejps.2025.107185_bib0008","series-title":"European Medicines Agency Updates Guideline On Drug Interactions","year":"2012"},{"key":"10.1016\/j.ejps.2025.107185_bib0009","unstructured":"FDA. 2022. Assessing the effects of food on drugs in INDs and NDAs \u2014 Clinical pharmacology considerations guidance for industry. ed."},{"key":"10.1016\/j.ejps.2025.107185_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107150","article-title":"Tiny-TIM intestinal fluids versus human intestinal fluids: a comparison of the composition and their solubilizing capacity for poorly soluble drugs","volume":"211","author":"Goovaerts","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.ejps.2025.107185_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13546","article-title":"Advances in the physiology of gastric emptying","volume":"31","author":"Goyal","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ejps.2025.107185_bib0012","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/bi00460a012","article-title":"Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings","volume":"29","author":"Hernell","year":"1990","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ejps.2025.107185_bib0013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jps.20477","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol)","volume":"95","author":"Kalantzi","year":"2006","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.ejps.2025.107185_bib0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1023\/B:PHAM.0000016283.87709.a9","article-title":"Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids","volume":"21","author":"Kaukonen","year":"2004","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.ejps.2025.107185_bib0015","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1023\/A:1026155822121","article-title":"Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy","volume":"20","author":"Kelly","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.ejps.2025.107185_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114723","article-title":"Predicting the pharmacokinetics and food effect of oral drug products using the dynamic gastrointestinal model (DGM)","volume":"212","author":"Knopp","year":"2025","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejps.2025.107185_bib0017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejps.2015.11.012","article-title":"An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: design, implementation, and evaluation","volume":"82","author":"Kourentas","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.ejps.2025.107185_bib0018","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/mp500022u","article-title":"Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI","volume":"11","author":"Koziolek","year":"2014","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.ejps.2025.107185_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-017-2289-x","article-title":"Lipids in the stomach - implications for the evaluation of food effects on oral drug absorption","volume":"35","author":"Koziolek","year":"2018","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.ejps.2025.107185_bib0020","first-page":"G951","article-title":"Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism","volume":"273","author":"Levitt","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ejps.2025.107185_bib38","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S57565","article-title":"Formulation and delivery of itraconazole to the brain using a nanolipid carrier system","volume":"9","author":"Lim","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"10.1016\/j.ejps.2025.107185_bib0022","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/acs.molpharmaceut.4c00202","article-title":"Physiologically based Biopharmaceutics modeling (PBBM): best practices for drug product quality, regulatory and industry perspectives: 2023 workshop summary report","volume":"21","author":"Mackie","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ejps.2025.107185_bib0023","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","article-title":"In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media","volume":"93","author":"Markopoulos","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejps.2025.107185_bib0024","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/mp200286x","article-title":"Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo","volume":"9","author":"M\u00fcllertz","year":"2012","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.ejps.2025.107185_bib0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jphp.12951","article-title":"In vitro methods to assess drug precipitation in the fasted small intestine - a PEARRL review","volume":"71","author":"O'Dwyer","year":"2019","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.ejps.2025.107185_bib0026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-5173(87)90182-7","article-title":"The influence of food on the gastric emptying of multiparticulate dosage forms","volume":"34","author":"O'Reilly","year":"1987","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejps.2025.107185_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105351","article-title":"Disposition of two highly permeable drugs in the upper gastrointestinal lumen of healthy adults after a standard high-calorie, high-fat meal","volume":"149","author":"Pentafragka","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.ejps.2025.107185_bib0029","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.xphs.2021.10.010","article-title":"In vitro simulation of the environment in the upper gastrointestinal lumen after drug administration in the fed State using the TIM-1 system and comparison with luminal data in adults","volume":"111","author":"Pentafragka","year":"2022","journal-title":"J Pharm Sci."},{"issue":"8","key":"10.1016\/j.ejps.2025.107185_bib0030","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1021\/acs.molpharmaceut.4c00526","article-title":"Parameterization of physiologically based biopharmaceutics models: workshop Summary report","volume":"21","author":"Pepin","year":"2024","journal-title":"Mol Pharm."},{"issue":"6","key":"10.1016\/j.ejps.2025.107185_bib0031","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jps.10126","article-title":"Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7","volume":"91","author":"Peeters","year":"2002","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.ejps.2025.107185_bib0032","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/acs.molpharmaceut.4c01038","article-title":"Simulation of antral conditions for estimating drug apparent equilibrium solubility after a high-calorie, high-fat meal","volume":"22","author":"Reppas","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ejps.2025.107185_bib0033","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jps.2600581117","article-title":"A simple dilution analog computer for simulation of drug distribution processes","volume":"58","author":"Rowe","year":"1969","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.ejps.2025.107185_bib0034","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/nu11051147","article-title":"Intraluminal impact of food: new insights from MRI","volume":"11","author":"Spiller","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejps.2025.107185_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acs.molpharmaceut.4c01148","article-title":"Current State and new horizons in applications of physiologically based biopharmaceutics modeling (PBBM): a workshop report","volume":"22","author":"Tannergren","year":"2025","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejps.2025.107185_bib0036","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/mp200479f","article-title":"Luminal lipid phases after administration of a triglyceride solution of Danazol in the Fed State and their contribution to the flux of Danazol across Caco-2 cell monolayers","volume":"9","author":"Vertzoni","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107185_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106788","article-title":"Predicting gastric emptying of drug substances taken under postprandial conditions by combination of biorelevant dissolution and mechanistic in silico modeling","volume":"198","author":"Winter","year":"2024","journal-title":"Eur J Pharm Sci"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T10:13:58Z","timestamp":1757844838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S0928098725001848"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107185","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro evaluation of drug presence in the upper small intestine when antro-duodenal drug transfer of a highly permeable drug occurs after a high-calorie, high-fat meal","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107185"}}